PFE vs SLB Stock Comparison: Price, Growth & Valuation (2026)
Use MEXC Stock Compare for a detailed PFE vs SLB analysis. Compare PFE and SLB across price performance, growth, valuation, profitability and risk, based on market data and the latest reported financials.
PFE vs SLB Stock Comparison Summary
PFE reported year-over-year revenue growth of -0.2%, compared with 2.5% for SLB. Their P/E ratios are 37.4x and 24.6x, dividend yields are 6.04% and 2.22%, and 30-day volatility levels are 19.5% and 34.1%, respectively. These metrics highlight key differences in growth, valuation, dividend income and market risk. Overall neither stock has a clear lead based on the selected metrics.
Risk Disclaimer: MEXC Stock Compare provides information and comparisons on actual U.S.-listed stocks for reference only. Data may be delayed or inaccurate, does not constitute investment advice, and past performance does not guarantee future results.
PFE vs SLB Stock Return Comparison (1W)
Compare the cumulative total returns of Pfizer Inc. (PFE) and SLB Limited (SLB) over the selected 1W period. Data as of 2026-09-25 12:00:00.
PFE vs SLB Key Equity Metrics Comparison Summary
Pfizer Inc. (PFE) has a market capitalization of $161.81B and operates in the Health Care sector, with its main business classified under Pharmaceuticals. Its latest quarterly revenue changed -0.2% year over year.
SLB Limited (SLB) has a market capitalization of $76.23B and operates in the Energy sector, with its main business classified under Oil & Gas Equipment & Services. Its latest quarterly revenue changed +2.5% year over year.
PFE vs SLB Key Stock Indicators
| Comparison Metric | PFE | SLB | Comparison results |
Stock Price & Returns Latest delayed stock price with 1-day, 1-month and year-to-date returns. | $28.391D: -0.1%1M: +1.4%1Y: +20.3% | $51.371D: -0.3%1M: -6.9%1Y: +48.2% | SLBWin |
Market Capitalization Total market value of the company's outstanding shares. | $161.81B | $76.23B | PFEWin |
Sector & Industry The company's market sector and primary industry classification. | Health Care / Pharmaceuticals | Energy / Oil & Gas Equipment & Services | -- |
| Based on delayed market data, PFE is trading at $28.39, compared with $51.37 for SLB. Their market capitalizations are $161.81B and $76.23B, respectively. PFE operates in the Health Care sector, while SLB belongs to Energy. | |||
| PFE vs SLB Growth & Profitability | |||
Revenue Growth (YoY) Year-over-year change in revenue. | -0.2% | +2.5% | SLBWin |
EPS Growth (YoY) Year-over-year change in earnings per share. | -59.6% | -29.5% | SLBWin |
ROIC Return generated from invested capital. | 7.3% | 9.2% | SLBWin |
Gross Margin / Operating Margin Profitability before and after operating expenses. | 73.2% / 21.7% | 16.5% / 11.4% | PFEWin |
| On growth, PFE posted revenue growth of -0.2% and TTM EPS growth of -59.6%. SLB, by comparison, posted revenue growth of +2.5% and TTM EPS growth of -29.5%.On profitability, PFE recorded a gross margin of 73.2%, an operating margin of 21.7%, and ROIC of 7.3%. For SLB, the corresponding figures were 16.5%, 11.4%, and 9.2%.Overall, the two stocks have different strengths across growth and profitability. | |||
| PFE vs SLB Valuation & Balance Sheet | |||
Free Cash Flow Yield Free cash flow as a percentage of market capitalization. | 6.8% | 6.3% | PFEWin |
Net Debt / EBITDA Net debt relative to EBITDA; a negative value indicates net cash. | 2.7x | 1.1x | SLBWin |
Dividend Yield / Payout Ratio Dividend returns relative to share price and the share of earnings paid as dividends. | 6.04% / 225.8% | 2.22% / 54.4% | PFEWin |
| PFE offers a higher free cash flow yield, indicating a less demanding valuation. SLB has the stronger balance sheet, while PFE provides the higher dividend yield. Overall, the two stocks differ mainly in valuation, financial strength and dividend income. | |||
| PFE vs SLB Returns & Risk | |||
Total Return (Dividend-Adjusted) Cumulative return over 1, 5 and 10 years, including dividends. | 1Y: +20.3%5Y: -34.8%10Y: -15.6% | 1Y: +48.2%5Y: +69.8%10Y: -32.2% | PFEWin |
30-Day Realized Volatility Annualized volatility based on the past 30 days of daily returns. | 19.5% | 34.1% | PFEWin |
Beta (5Y vs S&P 500) Sensitivity to market movements; above 1 indicates greater market volatility. | 0.40 | 0.83 | PFEWin |
| SLB has delivered stronger long-term returns, but SLB also shows higher recent volatility and market sensitivity. | |||
PFE vs SLB Valuation & Dividend Metrics
Review PFE compared with SLB across valuation, cash flow and dividend metrics, including P/E, forward P/E, free cash flow yield and dividend yield. These figures are provided for reference only and do not represent a fair-value estimate, price target or investment recommendation.
| Metric | PFE | SLB | Comparison results |
|---|---|---|---|
Market Cap | $161.81B | $76.23B | PFEWin |
P/E (TTM) | 37.4x | 24.6x | SLBWin |
P/S | 2.5x | 2.1x | SLBWin |
EV/EBITDA | 9.5x | 11.2x | PFEWin |
Dividend Yield | 6.04% | 2.22% | PFEWin |
PFE vs SLB Profitability Over Time
Compare PFE and SLB across gross margin and operating margin trends over time to understand how each company's profitability has changed. Based on reported financial data only; not a forecast or investment advice.
| TTM | 3Y Avg | 5Y Avg | 10Y Avg | |
|---|---|---|---|---|
| PFE | 74.3% | 68.1% | 66.5% | 72.6% |
| SLB | 18.2% | 19.5% | 18.6% | 15.5% |
Technical & Fundamental Stock Analysis
RSI (14, daily)
PFE 62.52 • SLB 40.12
Measures short-term price momentum and helps identify possible overbought or oversold conditions.
50/200-DMA Position
PFE 50D Above / 200D Above • SLB 50D Below / 200D Above
Shows whether the stock is trading above or below its medium- and long-term trend lines.
R&D % of Revenue
PFE 17.3% • SLB 1.9%
Shows how much of revenue is invested in research and development.
Share Count Trend (3Y)
PFE Stable • SLB Stable
Shows whether the company's share count has increased or decreased over the past three years.
Company Profiles
Pfizer Inc.
Pharmaceuticals
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
SLB Limited
Oil & Gas Equipment & Services
SLB is the world's premier oilfield-services company as measured by market share. While the industry is largely fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies in which it operates. Also known as Schlumberger, the company was founded in 1926 by Conrad and Marcel Schlumberger. Today, it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: core, digital, and new energy businesses. Over three-fourths of its revenue base is tied to international markets, while the company boasts nearly $3 billion in digital-related revenue.
Trade PFE & SLB Stock Futures on MEXC
Trade USDT-margined Stock Futures referencing PFE and SLB on MEXC, with 24/7 access and leverage of up to 10x. These products are derivatives, do not represent ownership of the underlying shares and involve a significant risk of loss.
Everything You Need to Know About PFE vs SLB Stocks
What is MEXC Stock Compare?
MEXC Stock Compare is a side-by-side US stock comparison tool. It helps users compare two companies across stock price performance, market cap, valuation, growth, profitability, balance-sheet strength, dividends and risk. The results are provided for research purposes only and do not constitute investment advice.
Which metrics should I use to evaluate a company's growth?
Start with revenue growth to see how quickly the business is expanding, then review EPS growth to determine whether that growth is translating into higher earnings per share. Gross margin, operating margin and ROIC help assess the quality of that growth by showing profitability and capital efficiency. A company with fast revenue growth but declining margins may be expanding without improving its earnings quality.
How do PFE and SLB compare in growth and profitability?
In the latest reported period, PFE recorded revenue growth of -0.2% and TTM EPS growth of -59.6%, compared with +2.5% and -29.5% for SLB. SLB leads on growth, while PFE has stronger profitability. This comparison is based on reported financial metrics and does not predict future performance.
What is the difference between P/E (TTM) and Forward P/E?
P/E (TTM) compares the current share price with actual earnings reported over the past 12 months. Forward P/E uses estimated earnings for the next 12 months, so it reflects market expectations but depends on forecasts that may change. Both ratios should be considered alongside growth, profitability and industry peers.
How do the risk profiles of PFE and SLB compare?
PFE has a 30-day realized volatility of 19.5% and a five-year Beta of 0.40, compared with 34.1% and 0.83 for SLB. SLB shows higher historical volatility and market sensitivity. These indicators describe historical price movements and market sensitivity, but they do not cover every source of investment risk.
What do dividend yield and payout ratio indicate?
Dividend yield shows the annual dividend relative to the current share price, while the payout ratio shows how much of a company's earnings is distributed as dividends. A higher yield may provide more income, but it can also rise because the share price has fallen. Dividend sustainability should therefore be considered together with earnings, cash flow and the payout ratio.
How should I compare a high-growth stock with a lower-valued stock?
A high-growth stock may trade at a higher valuation if investors expect its revenue and earnings to continue expanding. A lower-valued stock may offer a more conservative entry point, but the lower valuation could also reflect slower growth or higher business risk. Growth, valuation, profitability, cash flow and risk should therefore be considered together.
Which is the better stock, PFE or SLB?
There is no single answer for every investor. Growth-focused investors may place greater weight on revenue growth, EPS growth and ROIC, while income-focused investors may prioritize dividend yield and payout sustainability. Investors with lower risk tolerance may focus more on volatility, Beta and balance-sheet strength. MEXC Stock Compare presents the relevant metrics but does not provide a buy or sell recommendation.
Can I trade PFE and SLB as RealStocks on MEXC?
Eligible users can trade PFE and SLB as real US stocks through MEXC RealStocks if both stocks are currently supported. Users must first open and verify a RealStocks account with MEXC's partner licensed broker. RealStocks represents ownership of actual shares rather than tokenized stock exposure. Availability may vary by stock and region, so users should check the corresponding RealStocks trading page before placing an order.
Disclaimer
The stock prices, financial metrics, comparison results and related information displayed on this page are sourced from third-party providers and are provided for informational and educational purposes only. Data may be delayed, incomplete or inaccurate, and MEXC does not guarantee its accuracy, completeness or timeliness. The comparisons and automated summaries do not constitute financial, investment, legal or tax advice, nor a recommendation to buy, sell or hold any security or financial product. Past performance is not indicative of future results. Users should independently verify the information and assess their own objectives, financial circumstances and risk tolerance before making any decision. Where MEXC stock futures or other derivative products are referenced, such products do not represent ownership of the underlying shares and may involve leverage and a substantial risk of loss. Product availability is subject to applicable laws and regional restrictions.